Vanguard Global Advisers’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$652K Buy
6,080
+1,295
+27% +$84.8K ﹤0.01% 1981
2026
Q1
$37.8K Buy
+4,785
New +$77.4K ﹤0.01% 3130

Other funds holding AGL

Vanguard Global Advisers's AGL Position: Q2 2026 in Review

Vanguard Global Advisers increased its Agilon Health (AGL) stake by 27% in Q2 2026, buying an estimated $84.8K and bringing the position to 6,080 shares worth $652K. The position accounts for ﹤0.01% of the portfolio, ranked #1981.

Vanguard Global Advisers first reported a position in AGL in Q1 2026 and has held it in 2 quarters since. 175 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Vanguard Global Advisers held 6,080 shares of Agilon Health worth $652K as of Q2 2026.
  • Vanguard Global Advisers bought 1,295 Agilon Health shares in Q2 2026, an estimated $84.8K.
  • Agilon Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1981 holding.
  • Vanguard Global Advisers first reported a position in Agilon Health in Q1 2026 and has held it in 2 quarters since.
  • 175 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.